Login to Your Account

BIO 2014

Following the innovation road: down the critical path initiative

By Peter Winter

Monday, June 30, 2014

SAN DIEGO – A decade has transpired since the FDA released its seminal report Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products in March 2004. The FDA did not pull any punches at that time in identifying the industry's inability to improve on the run rate of new product development despite having at its disposal advanced discovery tools such as genomics and investing billions of dollars into research and development.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription